Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Arif Hakan Onder"'
Autor:
Arif Hakan Onder, Banu Ozturk, Murat Kocer, Deniz Ozbay Gediz, Derya Kivrak Salim, Mustafa Yildiz, Selami Bayram, Sevil Goktas
Publikováno v:
Medicine Science, Vol 12, Iss 3, Pp 827-52 (2023)
The aim of this study is to determine the discrepancy and agreement between Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scores evaluated by doctors and patients and examine the factors that influence the performance evaluation of
Externí odkaz:
https://doaj.org/article/69b5fb7a86fd46b99e2afca49d9a1cce
Publikováno v:
Annals of Saudi Medicine, Vol 43, Iss 1, Pp 1-9 (2023)
BACKGROUND: COVID-19 and solid cancer are both associated with an increased risk of thromboembolism. OBJECTIVES: Assess whether solid cancer is a risk factor for acute ischemic event development among patients with COVID-19. DESIGN: Retrospective coh
Externí odkaz:
https://doaj.org/article/8f48141242c741ee8a94c2d2fb2f69fa
Autor:
Erkan Kayikcioglu, Asim Armagan Aydin, Arif Hakan Onder, Alper Sayiner, Dinc Suren, Banu Ozturk
Publikováno v:
Journal of Oncological Sciences, Vol 3, Iss 2, Pp 84-86 (2017)
Histiocytic sarcoma (HS) is an extremely rare malignant neoplasm accounting for less than 1% of all hemato-lymphoid neoplasms. Sixty percent of all cases are metastatic at presentation and the prognosis is poor. Two cases of HS with an aggressive cli
Externí odkaz:
https://doaj.org/article/f41fc03e555e47488e6ba6ebc9740dd0
Autor:
Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir, Rukiye Arikan, Seval Ay, Muhammet Ozer, Murat Ayhan, Ibrahim Cil, Nazan Demir, Neslihan Ozyurt, Gökhan Karakaya, Gokcen Tugba Cevik, Arif Hakan Onder, Oguzhan Selvi, Abdullah Sakin
The aim of this multicentre retrospective study was to compare the efficacy of adjuvant chemotherapy regimens both with and without oxaliplatin and tumor sidedness in stage IIB (pT4aN0) colon cancer patients. This study included patients with stage I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb53b257b4234927987052f53a720d9f
https://hdl.handle.net/11424/287169
https://hdl.handle.net/11424/287169
Autor:
Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir, Binnur Dönmez Yilmaz, Tugba Akin Telli, Orcun Can, Ibrahim Cil, Sabin Goktas Aydın, Neslihan Ozyurt, Arif Hakan Onder, Oguzhan Selvi, Abdullah Sakin
Publikováno v:
Oncology Research and Treatment. 45:254-261
Introduction: A significant proportion of cervical cancer (CC) patients are diagnosed at a locally advanced stage. Concurrent chemoradiotherapy (CCRT) is the cornerstone of treatment for patients with locally advanced CC. However, the role of adjuvan
Autor:
Arif Hakan ONDER, Derya KIVRAK SALİM, Mustafa KARACA, Selami BAYRAM, Armağan AYDIN, Sevil GÖKTAŞ, Murat KOÇER, Deniz ÖZBAY GEDİZ, Mustafa YILDIZ, Banu ÖZTÜRK
Publikováno v:
Volume: 44, Issue: 4 384-389
Cumhuriyet Tıp Dergisi
Cumhuriyet Medical Journal
Cumhuriyet Tıp Dergisi
Cumhuriyet Medical Journal
İntroduction and aim: Cancer affects people psychologically and organically. The emotional state of cancer patients is fragile and can be affected by many factors. We aimed to evaluate the effect of the Covid-19 pandemic on the mood and behavioral c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a899aeff6854bbc60d8d81c9244488d6
https://dergipark.org.tr/tr/pub/cmj/issue/74897/1210488
https://dergipark.org.tr/tr/pub/cmj/issue/74897/1210488
Autor:
Elvina Almuradova, Tugba Basoglu, Erdinc Nayir, Ertugrul Bayram, Semra Paydas, Ivo Gokmen, Serdar Karakaya, Berna Oksuzoglu, Dilek Erdem, Abdullah Sakin, Mustafa Atcı, Burcu Belen Gulbagcı, Ilhan Hacibekiroglu, Arif Hakan Onder, Serap Karaarslan, Melek Karakurt Eryilmaz, Mustafa Korkmaz, Ozan Yazıcı, Osman Sutcuoglu, Baran Akagunduz, Hacı Arak, Teoman Sakalar, Dincer Aydın, Yakup Iriagac, Ozkan Alan, Murat Midik, Denis Cetin, Asli Dilara Kip, Serdar Turhal, Turgut Kacan, Tolga Koseci
Publikováno v:
Neoplasma.
Sarcomatoid renal cell carcinoma (sRCC) is a rare variant of renal cell carcinoma (RCC) and is associated with a poor prognosis. We reviewed the outcomes of patients from oncology centers in Turkey. Our aim is to share our real-life experience and to
Autor:
Elanur Karaman, Arife Ulas, Arif Hakan Onder, Adem Deligonul, Sibel O Orhan, Atilla Pekcolaklar
Publikováno v:
Cureus. 14(9)
Introduction Cancer patients are among the groups at high risk in the COVID-19 pandemic. Here, we aimed to determine the effectiveness of neoadjuvant chemotherapy (NACT) during the pandemic period and examine the prognostic factors in patients with n
Autor:
Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, Arif Hakan Onder, Fatih Kose, Caglayan Geredeli, Mustafa Karaagac, Muhammet Ali Kaplan, Mevlude Inanc, Sabin Goktas Aydin, Aysegul Kargi, Hacı Arak, Banu Ozturk, Ali Ayberk Besen, Oguzhan Selvi, Mustafa Korkmaz, Zeynep Oruc, Oktay Bozkurt, Ahmet Bilici, Selami Bayram, Shute Ailia Dae, Mustafa Ozdogan, Hasan Senol Coskun, Sema Sezgin Goksu
ObjectiveCisplatin-paclitaxel and bevacizumab is a frequently used treatment regimen for metastatic or recurrent cervical cancer, and carboplatin-paclitaxel and bevacizumab are also among the recommended regimens. In this study we aimed to evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a43bb00c7770acf17bbd73232c4c59
https://hdl.handle.net/20.500.12511/9393
https://hdl.handle.net/20.500.12511/9393
Autor:
Banu Ozturk, Halil Çelik, Kadir Eser, Ali Inal, Oğuzhan Kesen, Arif Hakan Onder, Emel Sezer, Tolga Koseci, Berna Bozkurt Duman, Timucin Cil, Vehbi Erçolak
IntroductionApproximately 20-33% of all cancer patients are treated with acid reducing agents (ARAs), most commonly proton pump inhibitors (PPIs), to reduce gastro esophageal reflux disease symptoms. Palbociclib and ribociclib are weak base so their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8ce0fc897954c78193d8f5058c56c75
https://doi.org/10.21203/rs.3.rs-1131962/v1
https://doi.org/10.21203/rs.3.rs-1131962/v1